Cargando…
A De Novo Cause of PGM3 Deficiency Treated with Hematopoietic Stem Cell Transplantation
Autores principales: | Winslow, Andrew, Jalazo, Elizabeth R., Evans, April, Winstead, Mike, Moran, Timothy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763434/ https://www.ncbi.nlm.nih.gov/pubmed/35040011 http://dx.doi.org/10.1007/s10875-021-01196-z |
Ejemplares similares
-
Successful heart transplantation in an infant with phosphoglucomutase 1 deficiency (PGM1‐CDG)
por: Altassan, Ruqaiah, et al.
Publicado: (2022) -
Hematopoietic Stem Cell Transplantation for XIAP Deficiency in Japan
por: Ono, Shintaro, et al.
Publicado: (2016) -
Outcomes of SARS-CoV2 infection in STAT3 and PGM3 Deficiency
por: Khalid, Muhammad, et al.
Publicado: (2021) -
In Vitro Skeletal Muscle Model of PGM1 Deficiency Reveals Altered Energy Homeostasis
por: Conte, Federica, et al.
Publicado: (2023) -
Case report: De novo SAMD9L truncation causes neonatal-onset autoinflammatory syndrome which was successfully treated with hematopoietic stem cell transplantation
por: Caldirola, María Soledad, et al.
Publicado: (2023)